Cite
HARVARD Citation
Guha, A. et al. (2021). Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries. Cancer medicine. pp. 3862-3872. [Online].